<DOC>
	<DOCNO>NCT02002806</DOCNO>
	<brief_summary>This randomize study surgery plus chemical nerve block versus surgery plus placebo pain control subject pancreatic cancer .</brief_summary>
	<brief_title>Surgery Plus Celiac Nerve Block Long-term Pancreatic Cancer Pain Control</brief_title>
	<detailed_description>Thi study pain control subject undergoing surgery pancreatic bile duct cancer . Subjects undergoing surgery randomize surgery plus celiac plexus neurolysis ethanol injection versus surgery plus placebo injection . Subjects follow every three month survivorship death ass pain , quality life measure , narcotic pain control usage . The primary endpoint pain control determine one year post surgery . Subjects require undergo additional diagnostic testing procedure part routine follow-up care .</detailed_description>
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>This study offer patient schedule undergo open laparoscopic operative resection presume pancreatic ( location ; i.e. , head , body , tail ) distal biliary tract cancer . Physiologic suitability major abdominal surgery Aged 18 year old Written inform consent Ability understand comply study guideline . Pregnancy Previous , preoperative celiac nerve block Neoadjuvant chemotherapy radiation therapy Incomplete tumor resection ( R2 resection , grossly positive resection margin ) Presumed ampullary duodenal cancer base preoperative workup intraoperative finding Benign tumor , neuroendocrine tumor , soft tissue tumor base preoperative workup intraoperative finding Known metastatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pancreatic cancer</keyword>
	<keyword>Pain</keyword>
</DOC>